A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis

Clinical trial NCT03783026 · COMPLETED

Trial details

NCT number: NCT03783026
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2019-02-06
Primary completion: 2021-10-26
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.